Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Lethargy, Pyrexia, Vaccination site discolouration, Vaccination site pain, Vaccination site pruritus
Clinical narrative: rare yeast infection/yeast infection and also looked like shingles; lethargic; red/black color at injections site/arm turned blackish and purple; Sore arm/sore for 1 week 10 days; itching sporadically at injection site; fever; chills; Headache; Hypersensitivity reaction; erythema/redness; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (rare yeast infection/yeast infection and also looked like shingles), LETHARGY (lethargic), ERYTHEMA (erythema/redness), VACCINATION SITE DISCOLOURATION (red/black color at injections site/arm turned blackish and purple) and VACCINATION SITE PAIN (Sore arm/sore for 1 week 10 days) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046b21A and 047a21a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Previously administered products included for Product used for unknown indication: tubersole in 2010. Past adverse reactions to the above products included Rash with tubersole. Concurrent medical conditions included Egg allergy (skin test), Sulfonamide allergy (Reaction occurred: rash), Penicillin allergy (Reaction occurred: itch) and Latex allergy. Concomitant products included LISINOPRIL from 2014 to an unknown date for Blood pressure high, HYDROCHLOROTHIAZIDE for Blood pressure increased, DIAZEPAM (VALIUM) from 1988 to an unknown date for Vestibular migraine, PROBIOTICS NOS and ESTROGENS CONJUGATED (PREMARIN) for an unknown indication.   On 29-Mar-2021 at 12:15 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Apr-2021 at 12:15 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Apr-2021, the patient experienced ERYTHEMA (erythema/redness) and HYPERSENSITIVITY (Hypersensitivity reaction). On an unknown date, the patient experienced HERPES ZOSTER (rare yeast infection/yeast infection and also looked like shingles), LETHARGY (lethargic), VACCINATION SITE DISCOLOURATION (red/black color at injections site/arm turned blackish and purple), VACCINATION SITE PAIN (Sore arm/sore for 1 week 10 days), VACCINATION SITE PRURITUS (itching sporadically at injection site), PYREXIA (fever), CHILLS (chills) and HEADACHE (Headache). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at a dose of 1 dosage form and FLUCONAZOLE for Yeast infection, at a dose of 1 dosage form. At the time of the report, HERPES ZOSTER (rare yeast infection/yeast infection and also looked like shingles), VACCINATION SITE DISCOLOURATION (red/black color at injections site/arm turned blackish and purple), VACCINATION SITE PAIN (Sore arm/sore for 1 week 10 days) and HEADACHE (Headache) had not resolved and LETHARGY (lethargic), ERYTHEMA (erythema/redness), HYPERSENSITIVITY (Hypersensitivity reaction), VACCINATION SITE PRURITUS (itching sporadically at injection site), PYREXIA (fever) and CHILLS (chills) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered HERPES ZOSTER (rare yeast infection/yeast infection and also looked like shingles), VACCINATION SITE DISCOLOURATION (red/black color at injections site/arm turned blackish and purple), VACCINATION SITE PAIN (Sore arm/sore for 1 week 10 days), HYPERSENSITIVITY (Hypersensitivity reaction) and HEADACHE (Headache) to be possibly related. No further causality assessments were provided for LETHARGY (lethargic), ERYTHEMA (erythema/redness), VACCINATION SITE PRURITUS (itching sporadically at injection site), PYREXIA (fever) and CHILLS (chills).    Patient experienced sore arm in the past with TB- testing. Treatment include anti-histamine cream.   Most recent FOLLOW-UP information incorporated above includes: On 01-Sep-2021: Follow up received and added past allergy due to vaccine  and concomitant medication and treatment medication.